-
Mashup Score: 2
Getting maximum value from these resources does first require that the specimens submitted to the Bank be of consistently high quality – that they comply with all requirements for labeling, collection, processing, storage, documentation, and shipping.
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20More Results: SWOG Trials That Keep on Giving | SWOG - 9 day(s) ago
S1216
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet-
Our @SWOGChair blog: More Results: SWOG Trials That Keep on Giving To keep @SWOG members informed of our research results, I'm highlighting important findings presented at two recent meetings, in #prostate cancer and rare #sarcomatoid carcinoma lung tumors https://t.co/S7v1ayFEx8 https://t.co/KVYurNewIm
-
-
Mashup Score: 9A Sneak Peek at Spring in Seattle | SWOG - 27 day(s) ago
As with last fall’s group meeting, you can install our meeting app on your smart phone (Android or Apple), or you can simply use the online version in a browser (no installation needed).
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Pilot Studies: When Efficacy Is Not the Primary Question | SWOG - 1 month(s) ago
Pilot studies can answer questions about whether a given trial design is feasible within the bounds of the National Clinical Trials Network and/or the NCI Community Oncology Research Program. They can tell us whether patients find a given intervention or approach acceptable, or whether we can enroll the right patients at the right rate of accrual.
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet-
Our @SWOGChair blog: Pilot Studies: When Efficacy Is Not the Primary Question Some of our studies are small-scale tests of methods & tools to be used in a scaled-up, definitive trial. @SWOG S1820, just published in the journal Cancer, was one such pilot. https://t.co/3hAvVZFwdu https://t.co/XJIiY3WMCa
-
-
Mashup Score: 1Better Integration of Community Oncologists into All We Do | SWOG - 2 month(s) ago
In recent years, community sites – specifically within the NCI Community Oncology Research Program (NCORP) – have accounted for about one-half of all SWOG-credited trial accrual. In fact, in 2023 the contribution of NCORP institutions was well over one-half of all enrollments. The challenge we face is ensuring community oncologists based at those sites are consistently well represented at the table through all stages of trial development and execution.
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11S2210 | SWOG - 2 month(s) ago
1. Disease Related Criteria Participant must have histologic diagnosis of prostate adenocarcinoma.Participant must have high or very high-risk disease defined by at least one of the following:cT3a to cT4xGrade Group 4 or 5 (Gleason sum 8-10)PSA > 20 ng/mL prior to registration Participant must have documented evidence of germline mutation (pathogenic/likely pathogenic variant) in BRCA2 or BRCA1…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet-
.@SWOG S2210 is now enrolling! Testing #neoadjuvant carboplatin in patients with high-risk localized #prostatecancer and a #BRCA1 or #BRCA2 germline mutation (per local lab). https://t.co/R38dZgdBuz #PCSM #urology PI: @heatherhcheng @FredHutch @UWMedicine @PCF_Science @PCaPROMISE https://t.co/pduAcXOxdX
-
-
Mashup Score: 21Carboplatin Chemotherapy Before Surgery For People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | SWOG - 2 month(s) ago
Clinical Trial Summary (S2210) What is the purpose of this clinical trial? This trial tests treatment for prostate cancer that is at high risk of spreading or coming back. Researchers want to find out if the chemotherapy drug carboplatin can help get rid of this type of cancer when it is given before surgery. The trial is for people…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Hope ... Springs Eternal | SWOG - 2 month(s) ago
Continuing that noble tradition, the newest Hope program is the Frank and Linda Meyskens Annual Endowed Lectureship on Advances in Cancer Prevention, which will sponsor a speaker every year at our spring group meeting. Gary Goodman, MD, has been selected as the first Meyskens Lecturer. Dr. Goodman seems an ideal choice.
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet-
Our @SWOGChair blog: Hope ... Springs Eternal The Hope Foundation for Cancer Research (@SupportingSWOG) is continuously developing new ways to support @SWOG strategic priorities for advancing #CancerResearch & improving patients' lives. Here are the latest https://t.co/S5QUJMXizm https://t.co/Cs8KnypF4e
-
-
Mashup Score: 21Carboplatin Chemotherapy Before Surgery For People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | SWOG - 2 month(s) ago
Clinical Trial Summary (S2210) What is the purpose of this clinical trial? This trial tests treatment for prostate cancer that is at high risk of spreading or coming back. Researchers want to find out if the chemotherapy drug carboplatin can help get rid of this type of cancer when it is given before surgery. The trial is for people…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 18Carboplatin Chemotherapy Before Surgery For People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | SWOG - 2 month(s) ago
Clinical Trial Summary (S2210) What is the purpose of this clinical trial? This trial tests treatment for prostate cancer that is at high risk of spreading or coming back. Researchers want to find out if the chemotherapy drug carboplatin can help get rid of this type of cancer when it is given before surgery. The trial is for people…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
Our @SWOGChair blog: Biospecimen Quality: Protecting the Value of Our Biobank Currency Getting full value from our biobank resources requires that submissions be of consistently high quality. We've posted new resources to help make that easier to achieve. https://t.co/pAwvSEMZqN https://t.co/KzJ5HipK4Y